FDA Approves Ovarian Cancer Drug Lynparza

December 20, 2014 6:56 PM

19 0

The U.S. Food and Drug Administration has just approved a new drug for the treatment of advanced ovarian cancer, along with an accompanying test that helps to better identify patients who might be eligible for treatment.

The new drug is called olaparib, but will be released on the market under the brand name Lynparza. It belongs to a relatively new class of drugs that are called ADP-ribose polymerase (PARP). The drug is intended to help women who have already received very extensive treatment for advanced ovarian ca...

Read more

To category page